Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy.

J Immunother Cancer · 2023 · PMC10040073 · PMID 36948507

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

borderline significancep=0.055so close (0.05 < p ≤ 0.1)

Of note, the univariate analysis showed borderline significance for reduced survival among patients who received single-agent nivolumab (HR: 2.04, p=0.055).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.